May 2013
3 tags
May 19th
5 notes
3 tags
May 19th
12 notes
1 tag
May 19th
12 notes
6 tags
May 18th
31 notes
7 tags
May 18th
18 notes
7 tags
May 18th
15 notes
6 tags
May 18th
15 notes
7 tags
May 18th
15 notes
7 tags
May 17th
26 notes
7 tags
May 17th
9 notes
8 tags
May 17th
22 notes
9 tags
May 17th
11 notes
8 tags
May 17th
7 notes
7 tags
May 17th
12 notes
6 tags
May 17th
9 notes
7 tags
May 17th
9 notes
1 tag
May 17th
3 tags
This is an excerpt from a story by CNN Fortune about long-term corruption inside Ranbaxy, a generic drugmaker. Ranbaxy makes, among other drugs, a generic form of Lipitor. …Just three decades ago, generic drug companies in the U.S. were derided as patent breakers. They had no clear way to gain FDA approval, while brand-name-drug companies had a lock on the market. The 1984 Hatch-Waxman Act...
May 17th
2 tags
May 17th
4 notes
7 tags
May 17th
21 notes
9 tags
May 17th
13 notes
8 tags
May 17th
4 notes
5 tags
May 16th
11 notes
6 tags
May 16th
8 notes
2 tags
Our Feel-Good War on Breast Cancer // NYTimes... →
This article by Peggy Orenstein examines the American approach to breast cancer— from the effectiveness of screening and treatment to the dangers of misconceptions and misrepresentations. published in the April 28, 2013, issue of The New York Times Magazine // blogmed
May 15th
2 notes
4 tags
May 15th
8 notes
7 tags
May 15th
38 notes
9 tags
May 15th
858 notes
5 tags
May 15th
6,780 notes
4 tags
May 15th
9,681 notes
8 tags
May 15th
2 notes
6 tags
May 15th
8 notes
7 tags
May 15th
5 notes
7 tags
May 15th
2 notes
3 tags
May 15th
110,512 notes
9 tags
May 15th
16 notes
7 tags
May 15th
17 notes
7 tags
May 14th
387 notes
7 tags
May 14th
8 notes
6 tags
May 14th
11 notes
7 tags
May 14th
3 notes
7 tags
May 14th
3 notes
8 tags
May 14th
1 note
11 tags
May 14th
7 notes
12 tags
May 14th
6 notes
10 tags
May 14th
12 notes
9 tags
May 14th
1 note
9 tags
May 14th
2 notes
9 tags
May 14th
2 notes
9 tags
May 14th
6 notes